Cantor Fitzgerald’s Aurinia Pharmaceuticals AUPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $578K | Buy |
+68,196
| New | +$578K | 0.01% | 180 |
|
|
2025
Q1 | – | Sell |
-72,000
| Closed | -$647K | – | 296 |
|
|
2024
Q4 | $647K | Buy |
+72,000
| New | +$647K | 0.01% | 82 |
|
|
2024
Q2 | – | Sell |
-54,033
| Closed | -$271K | – | 232 |
|
|
2024
Q1 | $271K | Sell |
54,033
-91,277
| -63% | -$457K | 0.06% | 126 |
|
|
2023
Q4 | $1.31M | Buy |
145,310
+44,855
| +45% | +$403K | 0.27% | 52 |
|
|
2023
Q3 | $781K | Buy |
100,455
+26,799
| +36% | +$208K | 0.02% | 288 |
|
|
2023
Q2 | $713K | Sell |
73,656
-3,077
| -4% | -$29.8K | 0.02% | 330 |
|
|
2023
Q1 | $841K | Buy |
76,733
+24,780
| +48% | +$272K | 0.02% | 385 |
|
|
2022
Q4 | $224K | Sell |
51,953
-99,690
| -66% | -$430K | ﹤0.01% | 557 |
|
|
2022
Q3 | $1.14M | Sell |
151,643
-15,580
| -9% | -$117K | 0.02% | 409 |
|
|
2022
Q2 | $1.68M | Buy |
+167,223
| New | +$1.68M | 0.03% | 389 |
|